ID   MICB_HUMAN              Reviewed;         383 AA.
AC   Q29980; A2AC57; A6NP85; B0UZ10; B2RAK2; O14499; O14500; O19798; O19799;
AC   O19800; O19801; O19802; O19803; O78099; O78100; O78101; O78102; O78103;
AC   O78104; P79525; P79541; Q5GR31; Q5GR37; Q5GR41; Q5GR42; Q5GR43; Q5GR44;
AC   Q5GR46; Q5GR48; Q5RIY6; Q5SSK1; Q5ST25; Q7JK51; Q7YQ89; Q861E6; Q9MY18;
AC   Q9MY19; Q9MY20; Q9UBH4; Q9UBZ8; Q9UEJ0; X6R344;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   12-AUG-2020, sequence version 2.
DT   28-JUN-2023, entry version 177.
DE   RecName: Full=MHC class I polypeptide-related sequence B;
DE            Short=MIC-B;
DE   Flags: Precursor;
GN   Name=MICB {ECO:0000312|EMBL:CAA62823.1};
GN   Synonyms=PERB11.2 {ECO:0000312|EMBL:AAB51802.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAA62823.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE MICB*001; ISOFORM 1).
RX   PubMed=8575823; DOI=10.1007/bf00587305;
RA   Bahram S., Spies T.;
RT   "Nucleotide sequence of a human MHC class I MICB cDNA.";
RL   Immunogenetics 43:230-233(1996).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAB42011.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE MICB*002; ISOFORM 1).
RX   PubMed=8952966; DOI=10.1007/s002510050184;
RA   Bahram S., Shiina T., Oka A., Tamiya G., Inoko H.;
RT   "Genomic structure of the human MHC class I MICB gene.";
RL   Immunogenetics 45:161-162(1996).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:ABO16470.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE MICB*005; ISOFORM 1), AND
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=17678727; DOI=10.1016/j.humimm.2007.05.003;
RA   Martinez-Borra J., Rodrigo L., Rodriguez-Rodero S., Fernandez-Morera J.L.,
RA   Diaz-Pena R., Pruneda L., Lopez-Vazquez A., Lopez-Larrea C.;
RT   "The allele MICB*0050204, over-represented in the Caucasian population, has
RT   an additional exon resulting from a new splice junction sequence.";
RL   Hum. Immunol. 68:705-707(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS GLU-39;
RP   GLU-80; ASN-136 AND VAL-300.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:BAB63307.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE MICB*002).
RA   Hirakawa M., Yamaguchi H., Imai K., Shimada J., Shiina S., Tamiya G.,
RA   Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305, ECO:0000312|EMBL:CR753864}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES MICB*002; MICB*003;
RP   MICB*004; MICB*005 AND MICB*008).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS GLU-39;
RP   GLU-80 AND VAL-300.
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAB51802.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-341 (ALLELE MICB*003; ISOFORM 1).
RX   PubMed=8995188; DOI=10.1007/s002510050191;
RA   Gaudieri S., Leelayuwat C., Townend D.C., Mullberg J., Cosman D.,
RA   Dawkins R.L.;
RT   "Allelic and interlocus comparison of the PERB11 multigene family in the
RT   MHC.";
RL   Immunogenetics 45:209-216(1997).
RN   [9] {ECO:0000305, ECO:0000312|EMBL:AAB71642.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-341 (ALLELES MICB*002; MICB*003; MICB*004;
RP   MICB*005 AND MICB*006; ISOFORM 1).
RX   PubMed=9271635; DOI=10.1007/s002510050299;
RA   Pellet P., Renaud M., Fodil N., Laloux L., Inoko H., Hauptmann G.,
RA   Debre P., Bahram S., Theodorou I.;
RT   "Allelic repertoire of the human MICB gene.";
RL   Immunogenetics 46:434-436(1997).
RN   [10] {ECO:0000305, ECO:0000312|EMBL:CAD91554.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 24-341 (ALLELE MICB*015; ISOFORM 1).
RC   TISSUE=Blood {ECO:0000312|EMBL:CAD91554.1};
RX   PubMed=15191526; DOI=10.1111/j.1399-0039.2004.00242.x;
RA   Quiroga I., Sweeney D., Sutton P.M., Chapple S.D.J., Souto-Grando J.P.,
RA   Barnardo M.C.N.M., Fuggle S.V.;
RT   "A novel major histocompatibility complex class I-related chain allele.";
RL   Tissue Antigens 64:74-77(2004).
RN   [11] {ECO:0000305, ECO:0000312|EMBL:AAC39847.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 25-383 (ALLELES MICB*002; MICB*005; MICB*008;
RP   MICB*010; MICB*011 AND MICB*012; ISOFORM 1).
RX   PubMed=9694358; DOI=10.1111/j.1399-0039.1998.tb03008.x;
RA   Visser C.J., Tilanus M.G., Schaeffer V., Tatari Z., Tamouza R., Janin A.,
RA   Charron D.;
RT   "Sequencing-based typing reveals six novel MHC class I chain-related gene B
RT   (MICB) alleles.";
RL   Tissue Antigens 51:649-652(1998).
RN   [12] {ECO:0000305, ECO:0000312|EMBL:BAA23479.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-341 (ALLELES MICB*002; MICB*003;
RP   MICB*004; MICB*005; MICB*007 AND MICB*008; ISOFORM 1).
RX   PubMed=9321430; DOI=10.1007/s002510050311;
RA   Ando H., Mizuki N., Ota M., Yamazaki M., Ohno S., Goto K., Miyata Y.,
RA   Wakisaka K., Bahram S., Inoko H.;
RT   "Allelic variants of the human MHC class I chain-related B gene (MICB).";
RL   Immunogenetics 46:499-508(1997).
RN   [13] {ECO:0000305, ECO:0000312|EMBL:CAB72097.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-341 (ALLELES MICB*008; MICB*013 AND
RP   MICB*014; ISOFORM 1).
RX   PubMed=10746790; DOI=10.1034/j.1399-0039.2000.550210.x;
RA   Fischer G., Perez-Rodriguez M., Arguello J.R., Cox S.T., McWhinnie A.,
RA   Travers P.J., Madrigal J.A.;
RT   "Three novel MICB alleles.";
RL   Tissue Antigens 55:166-170(2000).
RN   [14] {ECO:0000305, ECO:0000312|EMBL:CAE54939.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-297 (ALLELES MICB*005; MICB*014;
RP   MICB*016; MICB*018; MICB*019; MICB*020 AND MICB*022; ISOFORM 1).
RX   PubMed=15304008; DOI=10.1111/j.1399-0039.2004.00286.x;
RA   Schroeder M., Elsner H.-A., Kim T.D., Blasczyk R.;
RT   "Eight novel MICB alleles, including a null allele, identified in gastric
RT   MALT lymphoma patients.";
RL   Tissue Antigens 64:276-280(2004).
RN   [15] {ECO:0000305}
RP   FUNCTION, AND INDUCTION.
RX   PubMed=9497295; DOI=10.1126/science.279.5357.1737;
RA   Groh V., Steinle A., Bauer S., Spies T.;
RT   "Recognition of stress-induced MHC molecules by intestinal epithelial
RT   gammadelta T cells.";
RL   Science 279:1737-1740(1998).
RN   [16] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=10359807; DOI=10.1073/pnas.96.12.6879;
RA   Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T.;
RT   "Broad tumor-associated expression and recognition by tumor-derived gamma
RT   delta T cells of MICA and MICB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:6879-6884(1999).
RN   [17] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=11287116; DOI=10.1016/s0304-4165(01)00099-x;
RA   Yamamoto K., Fujiyama Y., Andoh A., Bamba T., Okabe H.;
RT   "Oxidative stress increases MICA and MICB gene expression in the human
RT   colon carcinoma cell line (CaCo-2).";
RL   Biochim. Biophys. Acta 1526:10-12(2001).
RN   [18] {ECO:0000305}
RP   INTERACTION WITH CYTOMEGALOVIRUS GLYCOPROTEIN UL16 (MICROBIAL INFECTION).
RX   PubMed=11239445; DOI=10.1016/s1074-7613(01)00095-4;
RA   Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W.,
RA   Kubin M., Chalupny N.J.;
RT   "ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16
RT   and stimulate NK cytotoxicity through the NKG2D receptor.";
RL   Immunity 14:123-133(2001).
RN   [19] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH KLRK1.
RX   PubMed=11491531; DOI=10.1007/s002510100325;
RA   Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K.,
RA   Spies T.;
RT   "Interactions of human NKG2D with its ligands MICA, MICB, and homologs of
RT   the mouse RAE-1 protein family.";
RL   Immunogenetics 53:279-287(2001).
RN   [20] {ECO:0000305}
RP   ALTERNATIVE SPLICING.
RX   PubMed=12466900; DOI=10.1007/s00251-002-0496-y;
RA   Zou Y., Stastny P.;
RT   "Alternatively spliced forms of MICA and MICB lacking exon 3 in a human
RT   cell line and evidence of presence of similar RNA in human peripheral blood
RT   mononuclear cells.";
RL   Immunogenetics 54:671-674(2002).
RN   [21]
RP   FUNCTION AS A LIGAND FOR KLRK1.
RX   PubMed=11777960; DOI=10.4049/jimmunol.168.2.671;
RA   Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M.,
RA   Cosman D.;
RT   "UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D
RT   and activate multiple signaling pathways in primary NK cells.";
RL   J. Immunol. 168:671-679(2002).
RN   [22] {ECO:0000305}
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=12569559; DOI=10.1002/ijc.10966;
RA   Jinushi M., Takehara T., Tatsumi T., Kanto T., Groh V., Spies T.,
RA   Kimura R., Miyagi T., Mochizuki K., Sasaki Y., Hayashi N.;
RT   "Expression and role of MICA and MICB in human hepatocellular carcinomas
RT   and their regulation by retinoic acid.";
RL   Int. J. Cancer 104:354-361(2003).
RN   [23] {ECO:0000305}
RP   INTERACTION WITH CYTOMEGALOVIRUS GLYCOPROTEIN UL16, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12782710; DOI=10.1084/jem.20022059;
RA   Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V.,
RA   Johnson D.C., Cosman D.;
RT   "Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration
RT   of NKG2D ligands, protecting against natural killer cell cytotoxicity.";
RL   J. Exp. Med. 197:1427-1439(2003).
RN   [24] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=12538683; DOI=10.4049/jimmunol.170.3.1249;
RA   Jinushi M., Takehara T., Kanto T., Tatsumi T., Groh V., Spies T.,
RA   Miyagi T., Suzuki T., Sasaki Y., Hayashi N.;
RT   "Critical role of MHC class I-related chain A and B expression on IFN-
RT   alpha-stimulated dendritic cells in NK cell activation: impairment in
RT   chronic hepatitis C virus infection.";
RL   J. Immunol. 170:1249-1256(2003).
RN   [25] {ECO:0000305}
RP   PROTEOLYTIC CLEAVAGE ON TUMOR CELLS.
RX   PubMed=16698441; DOI=10.1016/j.humimm.2006.02.008;
RA   Salih H.R., Goehlsdorf D., Steinle A.;
RT   "Release of MICB molecules by tumor cells: mechanism and soluble MICB in
RT   sera of cancer patients.";
RL   Hum. Immunol. 67:188-195(2006).
RN   [26] {ECO:0000305}
RP   INTERACTION WITH KLRK1.
RX   PubMed=16849432; DOI=10.1073/pnas.0600721103;
RA   Roda-Navarro P., Vales-Gomez M., Chisholm S.E., Reyburn H.T.;
RT   "Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse
RT   correlates with a reduction in NK cell cytotoxic function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11258-11263(2006).
RN   [27] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=17565371; DOI=10.1371/journal.pone.0000518;
RA   Schrambach S., Ardizzone M., Leymarie V., Sibilia J., Bahram S.;
RT   "In vivo expression pattern of MICA and MICB and its relevance to auto-
RT   immunity and cancer.";
RL   PLoS ONE 2:E518-E518(2007).
RN   [28] {ECO:0000305}
RP   INVOLVEMENT IN RHEUMATOID ARTHRITIS.
RX   PubMed=17003176; DOI=10.1093/rheumatology/kel331;
RA   Lopez-Arbesu R., Ballina-Garcia F.J., Alperi-Lopez M., Lopez-Soto A.,
RA   Rodriguez-Rodero S., Martinez-Borra J., Lopez-Vazquez A.,
RA   Fernandez-Morera J.L., Riestra-Noriega J.L., Queiro-Silva R.,
RA   Quinones-Lombrana A., Lopez-Larrea C., Gonzalez S.;
RT   "MHC class I chain-related gene B (MICB) is associated with rheumatoid
RT   arthritis susceptibility.";
RL   Rheumatology 46:426-430(2007).
RN   [29] {ECO:0000305}
RP   INVOLVEMENT IN SCHIZOPHRENIA.
RX   PubMed=17561376; DOI=10.1016/j.schres.2007.04.021;
RA   Shirts B.H., Kim J.J., Reich S., Dickerson F.B., Yolken R.H., Devlin B.,
RA   Nimgaonkar V.L.;
RT   "Polymorphisms in MICB are associated with human herpes virus
RT   seropositivity and schizophrenia risk.";
RL   Schizophr. Res. 94:342-353(2007).
RN   [30] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=17641203; DOI=10.1126/science.1140956;
RA   Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D.G., Saleh N.,
RA   Biton M., Horwitz E., Prokocimer Z., Prichard M., Hahn G., Goldman-Wohl D.,
RA   Greenfield C., Yagel S., Hengel H., Altuvia Y., Margalit H., Mandelboim O.;
RT   "Host immune system gene targeting by a viral miRNA.";
RL   Science 317:376-381(2007).
RN   [31] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=18395517; DOI=10.1016/j.bbrc.2008.03.131;
RA   Tang K.-F., He C.-X., Zeng G.-L., Wu J., Song G.-B., Shi Y.-S.,
RA   Zhang W.-G., Huang A.-L., Steinle A., Ren H.;
RT   "Induction of MHC class I-related chain B (MICB) by 5-aza-2'-
RT   deoxycytidine.";
RL   Biochem. Biophys. Res. Commun. 370:578-583(2008).
RN   [32]
RP   POLYMORPHISM.
RX   PubMed=32153595; DOI=10.3389/fimmu.2020.00314;
RA   Klussmeier A., Massalski C., Putke K., Schaefer G., Sauter J., Schefzyk D.,
RA   Pruschke J., Hofmann J., Fuerst D., Carapito R., Bahram S., Schmidt A.H.,
RA   Lange V.;
RT   "High-Throughput MICA/B Genotyping of Over Two Million Samples: Workflow
RT   and Allele Frequencies.";
RL   Front. Immunol. 11:314-314(2020).
RN   [33] {ECO:0000305}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 24-297, AND DISULFIDE BONDS.
RX   PubMed=12133964; DOI=10.4049/jimmunol.169.3.1395;
RA   Holmes M.A., Li P., Petersdorf E.W., Strong R.K.;
RT   "Structural studies of allelic diversity of the MHC class I homolog MIC-B,
RT   a stress-inducible ligand for the activating immunoreceptor NKG2D.";
RL   J. Immunol. 169:1395-1400(2002).
CC   -!- FUNCTION: Seems to have no role in antigen presentation. Acts as a
CC       stress-induced self-antigen that is recognized by gamma delta T cells.
CC       Ligand for the KLRK1/NKG2D receptor. Binding to KLRK1 leads to cell
CC       lysis. {ECO:0000269|PubMed:11491531, ECO:0000269|PubMed:11777960,
CC       ECO:0000269|PubMed:9497295}.
CC   -!- SUBUNIT: Unlike classical MHC class I molecules, does not form a
CC       heterodimer with beta-2-microglobulin. Binds as a monomer to a
CC       KLRK1/NKG2D homodimer. KLRK1 forms a complex with HCST/DAP10 in which
CC       KLRK1 binds MICB while HCST acts as an adapter molecule which enables
CC       signal transduction. Receptor-ligand interaction induces clustering of
CC       both proteins in ordered structures called immune synapses and also
CC       leads to their intercellular transfer. This is associated with a
CC       reduction in the cytotoxicity of KLRK1-expressing cells.
CC       {ECO:0000250|UniProtKB:Q29983, ECO:0000269|PubMed:11239445,
CC       ECO:0000269|PubMed:11491531, ECO:0000269|PubMed:12782710,
CC       ECO:0000269|PubMed:16849432}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human
CC       cytomegalovirus/HHV-5 glycoprotein UL16; this interaction causes
CC       sequestration of MICB in the endoplasmic reticulum and increases
CC       resistance to KLRK1-mediated cytotoxicity.
CC       {ECO:0000269|PubMed:11239445}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q29983};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q29983}.
CC       Note=Binding to human cytomegalovirus glycoprotein UL16 causes
CC       sequestration in the endoplasmic reticulum.
CC       {ECO:0000250|UniProtKB:Q29983, ECO:0000269|PubMed:12782710}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:12466900}; Synonyms=MICB1
CC       {ECO:0000269|PubMed:12466900};
CC         IsoId=Q29980-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:12466900}; Synonyms=MICB2
CC       {ECO:0000269|PubMed:12466900}, ex3-del;
CC         IsoId=Q29980-2; Sequence=VSP_055246;
CC       Name=3 {ECO:0000269|PubMed:17678727};
CC         IsoId=Q29980-3; Sequence=VSP_052801, VSP_052802;
CC   -!- TISSUE SPECIFICITY: Widely expressed with the exception of the central
CC       nervous system where it is absent. Expressed in many, but not all,
CC       epithelial tumors of lung, breast, kidney, ovary, prostate and colon.
CC       In hepatocellular carcinomas, expressed in tumor cells but not in
CC       surrounding non-cancerous tissue. {ECO:0000269|PubMed:10359807,
CC       ECO:0000269|PubMed:12569559, ECO:0000269|PubMed:17565371}.
CC   -!- INDUCTION: By heat shock, oxidative stress, retinoic acid, IFN-alpha
CC       and the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.
CC       Induction by IFN-alpha is impaired in patients with chronic hepatitis C
CC       virus infection. Down-regulated by human cytomegalovirus UL112 microRNA
CC       during viral infection which leads to decreased binding of KLRK1/NKG2D
CC       and reduced killing by natural killer cells.
CC       {ECO:0000269|PubMed:11287116, ECO:0000269|PubMed:12538683,
CC       ECO:0000269|PubMed:12569559, ECO:0000269|PubMed:17641203,
CC       ECO:0000269|PubMed:18395517, ECO:0000269|PubMed:9497295}.
CC   -!- PTM: Proteolytically cleaved and released from the cell surface of
CC       tumor cells. {ECO:0000269|PubMed:16698441}.
CC   -!- POLYMORPHISM: The following alleles of MICB are known: MICB*001,
CC       MICB*002, MICB*003, MICB*004, MICB*005, MICB*006, MICB*007, MICB*008,
CC       MICB*009N, MICB*010, MICB*011, MICB*012, MICB*013, MICB*014, MICB*015,
CC       MICB*016, MICB*018, MICB*019, MICB*020, MICB*021N and MICB*022.
CC       MICB*009N and MICB*021N are null alleles which are not expressed. The
CC       three most common MICB alleles in the human population could be
CC       MICB*005, MICB*004, and MICB*002. The sequence shown is that of
CC       MICB*004. {ECO:0000305|PubMed:32153595}.
CC   -!- DISEASE: Rheumatoid arthritis (RA) [MIM:180300]: An inflammatory
CC       disease with autoimmune features and a complex genetic component. It
CC       primarily affects the joints and is characterized by inflammatory
CC       changes in the synovial membranes and articular structures, widespread
CC       fibrinoid degeneration of the collagen fibers in mesenchymal tissues,
CC       and by atrophy and rarefaction of bony structures.
CC       {ECO:0000269|PubMed:17003176}. Note=Disease susceptibility is
CC       associated with variants affecting the gene represented in this entry.
CC       The MICB*004 allele is associated with rheumatoid arthritis.
CC   -!- DISEASE: Note=Genetic variation in MICB is associated with
CC       cytomegalovirus and herpes simplex virus I seropositivity and this may
CC       be associated with schizophrenia risk.
CC   -!- MISCELLANEOUS: [Isoform 3]: A GC to AG nucleotide substitution in
CC       intron 1 generates a splice junction which gives rise to an additional
CC       exon between exons 1 and 2. May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MHC class I family. MIC subfamily.
CC       {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X91625; CAA62823.1; -; mRNA.
DR   EMBL; U65416; AAB42011.1; -; Genomic_DNA.
DR   EMBL; AY885251; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; EF051579; ABO16470.1; -; Genomic_DNA.
DR   EMBL; EF051580; ABO16471.1; -; Genomic_DNA.
DR   EMBL; AK314228; BAG36899.1; -; mRNA.
DR   EMBL; BA000025; BAB63307.1; -; Genomic_DNA.
DR   EMBL; AL662866; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL663061; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX001040; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX005439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR753820; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR753864; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR788288; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC044218; AAH44218.1; -; mRNA.
DR   EMBL; U69978; AAB51802.1; -; Genomic_DNA.
DR   EMBL; U95729; AAB71642.1; -; mRNA.
DR   EMBL; U95730; AAB71643.1; -; mRNA.
DR   EMBL; U95731; AAB71644.1; -; mRNA.
DR   EMBL; U95732; AAB71645.1; -; mRNA.
DR   EMBL; U95733; AAB71646.1; -; mRNA.
DR   EMBL; U95734; AAB71647.1; -; mRNA.
DR   EMBL; AJ563706; CAD91554.1; -; Genomic_DNA.
DR   EMBL; AF021221; AAC39846.1; -; mRNA.
DR   EMBL; AF021222; AAC39847.1; -; mRNA.
DR   EMBL; AF021223; AAC39848.1; -; mRNA.
DR   EMBL; AF021224; AAC39849.1; -; mRNA.
DR   EMBL; AF021225; AAC39850.1; -; mRNA.
DR   EMBL; AF021226; AAC39851.1; -; mRNA.
DR   EMBL; AB003609; BAA23476.1; -; Genomic_DNA.
DR   EMBL; AB003610; BAA23477.1; -; Genomic_DNA.
DR   EMBL; AB003611; BAA23478.1; -; Genomic_DNA.
DR   EMBL; AB003612; BAA23479.1; -; Genomic_DNA.
DR   EMBL; AB003613; BAA23480.1; -; Genomic_DNA.
DR   EMBL; AB003614; BAA23481.1; -; Genomic_DNA.
DR   EMBL; AB003615; BAA23482.1; -; Genomic_DNA.
DR   EMBL; AB003616; BAA23483.1; -; Genomic_DNA.
DR   EMBL; AB003617; BAA23484.1; -; Genomic_DNA.
DR   EMBL; AJ251156; CAB72101.1; -; Genomic_DNA.
DR   EMBL; AJ251157; CAB72101.1; JOINED; Genomic_DNA.
DR   EMBL; AJ251158; CAB72097.1; -; Genomic_DNA.
DR   EMBL; AJ251159; CAB72097.1; JOINED; Genomic_DNA.
DR   EMBL; AJ251160; CAB72098.1; -; Genomic_DNA.
DR   EMBL; AJ251161; CAB72098.1; JOINED; Genomic_DNA.
DR   EMBL; AJ606906; CAE54932.1; -; Genomic_DNA.
DR   EMBL; AJ606907; CAE54933.1; -; Genomic_DNA.
DR   EMBL; AJ606908; CAE54934.1; -; Genomic_DNA.
DR   EMBL; AJ606909; CAE54935.1; -; Genomic_DNA.
DR   EMBL; AJ606910; CAE54936.1; -; Genomic_DNA.
DR   EMBL; AJ606911; CAE54937.1; -; Genomic_DNA.
DR   EMBL; AJ606912; CAE54938.1; -; Genomic_DNA.
DR   EMBL; AJ606913; CAE54939.1; -; Genomic_DNA.
DR   EMBL; AJ606914; CAE54940.1; -; Genomic_DNA.
DR   EMBL; AJ606915; CAE54941.1; -; Genomic_DNA.
DR   EMBL; AJ606916; CAE54942.1; -; Genomic_DNA.
DR   EMBL; AJ606917; CAE54943.1; -; Genomic_DNA.
DR   EMBL; AJ606918; CAE54944.1; -; Genomic_DNA.
DR   EMBL; AJ606919; CAE54945.1; -; Genomic_DNA.
DR   EMBL; AJ606920; CAE54946.1; -; Genomic_DNA.
DR   EMBL; AJ606921; CAE54947.1; -; Genomic_DNA.
DR   EMBL; AJ606922; CAE54948.1; -; Genomic_DNA.
DR   EMBL; AJ606923; CAE54949.1; -; Genomic_DNA.
DR   EMBL; AJ606929; CAE54955.1; -; Genomic_DNA.
DR   EMBL; AJ606930; CAE54956.1; -; Genomic_DNA.
DR   EMBL; AJ606931; CAE54957.1; -; Genomic_DNA.
DR   CCDS; CCDS43449.1; -. [Q29980-1]
DR   CCDS; CCDS75422.1; -. [Q29980-2]
DR   RefSeq; NP_001276089.1; NM_001289160.1.
DR   RefSeq; NP_001276090.1; NM_001289161.1. [Q29980-2]
DR   RefSeq; NP_005922.2; NM_005931.4. [Q29980-1]
DR   PDB; 1JE6; X-ray; 2.50 A; A=24-297.
DR   PDB; 2WY3; X-ray; 1.80 A; A/C=24-341.
DR   PDBsum; 1JE6; -.
DR   PDBsum; 2WY3; -.
DR   AlphaFoldDB; Q29980; -.
DR   SMR; Q29980; -.
DR   BioGRID; 110424; 157.
DR   CORUM; Q29980; -.
DR   STRING; 9606.ENSP00000252229; -.
DR   GlyCosmos; Q29980; 4 sites, No reported glycans.
DR   GlyGen; Q29980; 4 sites.
DR   iPTMnet; Q29980; -.
DR   PhosphoSitePlus; Q29980; -.
DR   SwissPalm; Q29980; -.
DR   BioMuta; MICB; -.
DR   DMDM; 74706857; -.
DR   EPD; Q29980; -.
DR   jPOST; Q29980; -.
DR   MassIVE; Q29980; -.
DR   MaxQB; Q29980; -.
DR   PaxDb; Q29980; -.
DR   PeptideAtlas; Q29980; -.
DR   ProteomicsDB; 3419; -.
DR   ProteomicsDB; 389; -.
DR   ProteomicsDB; 61282; -. [Q29980-1]
DR   ProteomicsDB; 69573; -.
DR   Antibodypedia; 27039; 333 antibodies from 28 providers.
DR   DNASU; 4277; -.
DR   Ensembl; ENST00000252229.7; ENSP00000252229.6; ENSG00000204516.10. [Q29980-1]
DR   Ensembl; ENST00000399150.7; ENSP00000382103.3; ENSG00000204516.10. [Q29980-2]
DR   Ensembl; ENST00000428416.2; ENSP00000398412.2; ENSG00000206449.11.
DR   Ensembl; ENST00000436531.6; ENSP00000409414.2; ENSG00000238289.9.
DR   Ensembl; ENST00000436655.2; ENSP00000402484.2; ENSG00000238289.9.
DR   Ensembl; ENST00000438954.6; ENSP00000398212.2; ENSG00000234218.9.
DR   Ensembl; ENST00000442104.6; ENSP00000387401.2; ENSG00000231179.9. [Q29980-2]
DR   Ensembl; ENST00000443156.2; ENSP00000393355.2; ENSG00000227772.8.
DR   Ensembl; ENST00000451603.6; ENSP00000407561.2; ENSG00000231179.9. [Q29980-1]
DR   GeneID; 4277; -.
DR   KEGG; hsa:4277; -.
DR   MANE-Select; ENST00000252229.7; ENSP00000252229.6; NM_005931.5; NP_005922.2.
DR   UCSC; uc003ntn.6; human.
DR   UCSC; uc003nto.6; human. [Q29980-1]
DR   AGR; HGNC:7091; -.
DR   CTD; 4277; -.
DR   DisGeNET; 4277; -.
DR   GeneCards; MICB; -.
DR   HGNC; HGNC:7091; MICB.
DR   HPA; ENSG00000204516; Tissue enhanced (lymphoid).
DR   MIM; 180300; phenotype.
DR   MIM; 602436; gene.
DR   neXtProt; NX_Q29980; -.
DR   OpenTargets; ENSG00000204516; -.
DR   PharmGKB; PA30812; -.
DR   VEuPathDB; HostDB:ENSG00000204516; -.
DR   eggNOG; ENOG502RU00; Eukaryota.
DR   GeneTree; ENSGT01090000260077; -.
DR   InParanoid; Q29980; -.
DR   OMA; NISVVWF; -.
DR   OrthoDB; 3840485at2759; -.
DR   PhylomeDB; Q29980; -.
DR   TreeFam; TF342166; -.
DR   PathwayCommons; Q29980; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q29980; -.
DR   BioGRID-ORCS; 4277; 23 hits in 1120 CRISPR screens.
DR   ChiTaRS; MICB; human.
DR   EvolutionaryTrace; Q29980; -.
DR   GenomeRNAi; 4277; -.
DR   Pharos; Q29980; Tbio.
DR   PRO; PR:Q29980; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q29980; protein.
DR   Bgee; ENSG00000204516; Expressed in granulocyte and 94 other tissues.
DR   ExpressionAtlas; Q29980; baseline and differential.
DR   Genevisible; Q29980; HS.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0002486; P:antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent; IBA:GO_Central.
DR   GO; GO:0002476; P:antigen processing and presentation of endogenous peptide antigen via MHC class Ib; IBA:GO_Central.
DR   GO; GO:0046629; P:gamma-delta T cell activation; IDA:UniProtKB.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0002429; P:immune response-activating cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0031640; P:killing of cells of another organism; IEA:UniProtKB-KW.
DR   GO; GO:0050689; P:negative regulation of defense response to virus by host; IDA:UniProtKB.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IBA:GO_Central.
DR   GO; GO:0009408; P:response to heat; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0032526; P:response to retinoic acid; IDA:UniProtKB.
DR   CDD; cd21017; IgC1_MHC_Ia_MIC-A_MIC-B; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 3.30.500.10; MHC class I-like antigen recognition-like; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011161; MHC_I-like_Ag-recog.
DR   InterPro; IPR037055; MHC_I-like_Ag-recog_sf.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   PANTHER; PTHR16675:SF154; MHC CLASS I POLYPEPTIDE-RELATED SEQUENCE A-RELATED; 1.
DR   PANTHER; PTHR16675; MHC CLASS I-RELATED; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00129; MHC_I; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   SUPFAM; SSF54452; MHC antigen-recognition domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell membrane;
KW   Cytolysis; Disulfide bond; Glycoprotein; Host-virus interaction; Immunity;
KW   Immunoglobulin domain; Membrane; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..383
FT                   /note="MHC class I polypeptide-related sequence B"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000341418"
FT   TOPO_DOM        23..309
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        310..330
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        331..383
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          207..298
FT                   /note="Ig-like C1-type"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        210
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        220
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        261
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        119..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:12133964"
FT   DISULFID        225..282
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:12133964"
FT   VAR_SEQ         24..41
FT                   /note="EPHSLRYNLMVLSQDGSV -> VEMGFHRVSQDGLDLLTS (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:17678727"
FT                   /id="VSP_052801"
FT   VAR_SEQ         42..383
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17678727"
FT                   /id="VSP_052802"
FT   VAR_SEQ         109..151
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_055246"
FT   VARIANT         39
FT                   /note="G -> E (in allele MICB*001; dbSNP:rs45578846)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_044068"
FT   VARIANT         68
FT                   /note="P -> H (in allele MICB*011; dbSNP:rs45583740)"
FT                   /id="VAR_044069"
FT   VARIANT         75
FT                   /note="N -> D (in allele MICB*001, allele MICB*002, allele
FT                   MICB*003, allele MICB*005, allele MICB*006, allele
FT                   MICB*007, allele MICB*008, allele MICB*010, allele
FT                   MICB*011, allele MICB*012, allele MICB*013, allele
FT                   MICB*014, allele MICB*015, allele MICB*016, allele
FT                   MICB*018, allele MICB*019 and allele MICB*022;
FT                   dbSNP:rs3131639)"
FT                   /id="VAR_044070"
FT   VARIANT         80
FT                   /note="K -> E (in allele MICB*002, allele MICB*007, allele
FT                   MICB*008, allele MICB*014, allele MICB*015, allele
FT                   MICB*016, allele MICB*019 and allele MICB*022;
FT                   dbSNP:rs1065075)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_044071"
FT   VARIANT         88
FT                   /note="D -> G (in allele MICB*022; dbSNP:rs45486091)"
FT                   /id="VAR_044072"
FT   VARIANT         105
FT                   /note="D -> G (in allele MICB*012; dbSNP:rs45502297)"
FT                   /id="VAR_044073"
FT   VARIANT         121
FT                   /note="I -> M (in allele MICB*008; dbSNP:rs3134900)"
FT                   /id="VAR_044074"
FT   VARIANT         136
FT                   /note="D -> H (in dbSNP:rs1051788)"
FT                   /id="VAR_059527"
FT   VARIANT         136
FT                   /note="D -> N (in allele MICB*002, allele MICB*007, allele
FT                   MICB*008, allele MICB*014, allele MICB*015, allele
FT                   MICB*018, allele MICB*020 and allele MICB*022;
FT                   dbSNP:rs1051788)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_044075"
FT   VARIANT         212
FT                   /note="T -> I (in allele MICB*003; dbSNP:rs41293883)"
FT                   /id="VAR_044076"
FT   VARIANT         215
FT                   /note="E -> K (in allele MICB*006 and allele MICB*015;
FT                   dbSNP:rs45624537)"
FT                   /id="VAR_044077"
FT   VARIANT         279
FT                   /note="R -> K (in allele MICB*007; dbSNP:rs45587032)"
FT                   /id="VAR_044078"
FT   VARIANT         291
FT                   /note="G -> S (in allele MICB*013, allele MICB*014, allele
FT                   MICB*015 and allele MICB*016; dbSNP:rs41273040)"
FT                   /id="VAR_044079"
FT   VARIANT         300
FT                   /note="A -> V (in allele MICB*001, allele MICB*016, allele
FT                   MICB*018, allele MICB*019, allele MICB*020 and allele
FT                   MICB*022; dbSNP:rs45470602)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_044080"
FT   VARIANT         383
FT                   /note="T -> A (in allele MICB*001, allele MICB*002, allele
FT                   MICB*005, allele MICB*006, allele MICB*007, allele
FT                   MICB*008, allele MICB*012, allele MICB*013, allele
FT                   MICB*014, allele MICB*015, allele MICB*016, allele
FT                   MICB*018, allele MICB*019, allele MICB*020 and allele
FT                   MICB*022; dbSNP:rs1065076)"
FT                   /id="VAR_044081"
FT   STRAND          26..37
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   STRAND          46..51
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   STRAND          54..60
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   TURN            61..64
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   STRAND          65..68
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   HELIX           71..75
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   HELIX           80..101
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          109..121
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   STRAND          123..125
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          127..135
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   STRAND          138..144
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   TURN            145..147
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   HELIX           156..170
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   HELIX           176..197
FT                   /evidence="ECO:0007829|PDB:2WY3"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          208..214
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          218..233
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          236..241
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          250..253
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          264..273
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   HELIX           277..279
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          280..286
FT                   /evidence="ECO:0007829|PDB:1JE6"
FT   STRAND          289..294
FT                   /evidence="ECO:0007829|PDB:1JE6"
SQ   SEQUENCE   383 AA;  42575 MW;  1309E571B48CDF9C CRC64;
     MGLGRVLLFL AVAFPFAPPA AAAEPHSLRY NLMVLSQDGS VQSGFLAEGH LDGQPFLRYD
     RQKRRAKPQG QWAENVLGAK TWDTETEDLT ENGQDLRRTL THIKDQKGGL HSLQEIRVCE
     IHEDSSTRGS RHFYYDGELF LSQNLETQES TVPQSSRAQT LAMNVTNFWK EDAMKTKTHY
     RAMQADCLQK LQRYLKSGVA IRRTVPPMVN VTCSEVSEGN ITVTCRASSF YPRNITLTWR
     QDGVSLSHNT QQWGDVLPDG NGTYQTWVAT RIRQGEEQRF TCYMEHSGNH GTHPVPSGKA
     LVLQSQRTDF PYVSAAMPCF VIIIILCVPC CKKKTSAAEG PELVSLQVLD QHPVGTGDHR
     DAAQLGFQPL MSATGSTGST EGT
//
